Literature DB >> 642032

Cell-cycle-specific chromosome damage following treatment of cultured Chinese hamster cells with 4'-[(9-acridinyl)-amino]methanesulphon-m-anisidide-HCl.

L L Deaven, M S Oka, R A Tobey.   

Abstract

The induction of chromosome damage in Chinese hamster (line CHO) cells by 4'-[(9-acridinyl)-amino]methanesulphon-m-anisidide-HCl (MAC) (NSC-141549) was studied in cell populations growing exponentially and at various stages of the cell cycle following release from isoleucine-deficient G1-arrest. Autoradiographic analysis demonstrated that cells in S-phase at time of drug addition (2 microgram MAC/ml for 2 hr) were delayed 8 hours before entering mitosis. Cells in G1 at the time of MAC treatment were not as severely delayed, which resulted in a rather sharp increase and decrease in a percent labeled mitosis curve. Chromosome damage occurred differentially during the cell cycle. Cells in late G2 during MAC treatment contained incompletely condensed chromosomes with occasional chromosome interchanges at the next mitosis. Early G2 cells were severely damaged (greater than 20 breaks/cell). Damage to cells in S or G1 at the time of MAC addition was less severe, whereas cells in G1-S traverse had intermediate levels of chromosome breaks. Thus MAC appeared to be particularly effective at times when chromatin was undergoing structural modifications (G1-S and S-G2 boundaries). Low concentrations of MAC (0.05 microgram/ml) increased the rate of sister chromatid exchange to almost eight times the background rate. The cellular effects of MAC were compared with previously reported studies of other antitumor agents.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 642032

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  9 in total

1.  Interaction of the antitumour drug 4'-(9-acridinylamino)-methanesulfon-m-anisidine.HCl (m-AMSA) with nucleic acids.

Authors:  F Hudecz; J Kajtár; M Szekerke
Journal:  Nucleic Acids Res       Date:  1981-12-21       Impact factor: 16.971

2.  Human cytomegalovirus induces expression of cellular topoisomerase II.

Authors:  J D Benson; E S Huang
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

3.  Two specific topoisomerase II inhibitors prevent replication of human cytomegalovirus DNA: an implied role in replication of the viral genome.

Authors:  J D Benson; E S Huang
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

4.  Chromosome recombination and defective genome segregation induced in Chinese hamster cells by the topoisomerase II inhibitor VM-26.

Authors:  M Charron; R Hancock
Journal:  Chromosoma       Date:  1991-02       Impact factor: 4.316

5.  Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.

Authors:  E M Nelson; K M Tewey; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

Review 6.  m-AMSA and PALA: two new agents in cancer chemotherapy.

Authors:  M Rozencweig; D D Von Hoff; R L Cysyk; F M Muggia
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

7.  Blocked 5'-termini in the fragments of chromosomal DNA produced in cells exposed to the antitumor drug 4'-[(9-acridinyl)-amino]methanesulphon-m-anisidide (mAMSA).

Authors:  B Marshall; R K Ralph; R Hancock
Journal:  Nucleic Acids Res       Date:  1983-06-25       Impact factor: 16.971

8.  A comparison of adriamycin and mAMSA. II. Studies with V79 and human tumour multicellular spheroids.

Authors:  C M West; I J Stratford
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

9.  A comparison of adriamycin and mAMSA in vitro: cell lethality and SCE studies.

Authors:  C West; I J Stratford; N Barrass; E Smith
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.